Synthesis of Novel Bis-pyrazole Derivatives as Antimicrobial Agents. 2019

Zeinab A Muhammad, and Fatimah Alshehrei, and Mohie E M Zayed, and Thoraya A Farghaly, and Magda A Abdallah
National Organization for Drug Control and Research (NODCAR), P.O. Box 29, Cairo, Egypt.

BACKGROUND Bis-heterocycles especially those containing pyrazole moiety display much better antibacterial activity than mono heterocycles. OBJECTIVE Herein, we synthesised a series of new bis-pyrazoles and investigated their antimicrobial agents. METHODS A novel series of bis-pyrazole derivatives have been synthesized in good yield by coupling reaction of cyanoacetic acid {4-[(2-cyano-acetyl)-hydrazonomethyl]-benzylidene}-hydrazide with a number of diazonium salts of aromatic amines in DMF in the presence of NaOH. Refluxing of the produced hydrazones with hydrazine-hydrate in ethanolic solution afforded the respective bis-pyrazoles. On the other hand, the reaction of bis(cyanoacetic acid hydrazide) derivative with a diversity of hydrazonoyl chlorides in dioxane under reflux gave bis-pyrazoles. RESULTS The structures of all the products were discussed and assured from all possible spectral data as well as for the elemental analysis. In addition, the results of the antimicrobial activity examination of selected derivatives revealed a high strength of some tested compounds compared to standard bactericides and fungicides utilized. Molecular docking of the newly synthesized compounds into the Enoyl ACP reductase active site supported the in vitro antimicrobial activity. All the tested compounds could fit in the enzyme binding pocket with significant binding affinities (-7.040 to -9.141 Kcal/mol). CONCLUSIONS The good results of the antimicrobial examination of the newly synthesized bis-pyrazoles comprise the considerable evidence of the importance of bis-heterocyclic compounds which encourages us to continue designing and synthesising a novel series with potent biological activity in the future.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005848 Geotrichum A mitosporic Saccharomycetales fungal genus, various species of which have been isolated from pulmonary lesions. Teleomorphs include Dipodascus and Galactomyces. Geotrichums
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D001234 Aspergillus niger An imperfect fungus causing smut or black mold of several fruits and vegetables such as grapes, apricots, onions, and peanuts, and is a common contaminant of food. Aspergillus lacticoffeatus
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Zeinab A Muhammad, and Fatimah Alshehrei, and Mohie E M Zayed, and Thoraya A Farghaly, and Magda A Abdallah
December 2017, Acta chimica Slovenica,
Zeinab A Muhammad, and Fatimah Alshehrei, and Mohie E M Zayed, and Thoraya A Farghaly, and Magda A Abdallah
March 2009, Medicinal chemistry (Shariqah (United Arab Emirates)),
Zeinab A Muhammad, and Fatimah Alshehrei, and Mohie E M Zayed, and Thoraya A Farghaly, and Magda A Abdallah
April 2005, Archiv der Pharmazie,
Zeinab A Muhammad, and Fatimah Alshehrei, and Mohie E M Zayed, and Thoraya A Farghaly, and Magda A Abdallah
November 1998, Die Pharmazie,
Zeinab A Muhammad, and Fatimah Alshehrei, and Mohie E M Zayed, and Thoraya A Farghaly, and Magda A Abdallah
April 2004, Bioorganic & medicinal chemistry,
Zeinab A Muhammad, and Fatimah Alshehrei, and Mohie E M Zayed, and Thoraya A Farghaly, and Magda A Abdallah
March 2012, Arzneimittel-Forschung,
Zeinab A Muhammad, and Fatimah Alshehrei, and Mohie E M Zayed, and Thoraya A Farghaly, and Magda A Abdallah
January 2010, Acta poloniae pharmaceutica,
Zeinab A Muhammad, and Fatimah Alshehrei, and Mohie E M Zayed, and Thoraya A Farghaly, and Magda A Abdallah
February 2017, Molecular and cellular biochemistry,
Zeinab A Muhammad, and Fatimah Alshehrei, and Mohie E M Zayed, and Thoraya A Farghaly, and Magda A Abdallah
June 2020, Molecules (Basel, Switzerland),
Zeinab A Muhammad, and Fatimah Alshehrei, and Mohie E M Zayed, and Thoraya A Farghaly, and Magda A Abdallah
June 2013, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!